Last reviewed · How we verify

Econazole Nitrate Cream 1% — Competitive Intelligence Brief

Econazole Nitrate Cream 1% (Econazole Nitrate Cream 1%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Imidazole antifungal. Area: Dermatology / Infectious Disease.

phase 3 Imidazole antifungal Lanosterol 14α-demethylase (CYP51) Dermatology / Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Econazole Nitrate Cream 1% (Econazole Nitrate Cream 1%) — AmDerma. Econazole nitrate is an imidazole antifungal that disrupts fungal cell membrane integrity by inhibiting ergosterol synthesis.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Econazole Nitrate Cream 1% TARGET Econazole Nitrate Cream 1% AmDerma phase 3 Imidazole antifungal Lanosterol 14α-demethylase (CYP51)
Monistat miconazole Johnson & Johnson (Janssen) marketed Imidazole antifungal 7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6 1974-01-01
Ketoconazole 2% Ketoconazole 2% University of California, Davis marketed Imidazole antifungal Fungal cytochrome P450 (CYP51 / lanosterol 14α-demethylase)
Clotrimazole 1% Clotrimazole 1% Jinnah Postgraduate Medical Centre marketed Imidazole antifungal Fungal cytochrome P450 (lanosterol 14α-demethylase)
Luliconazole Cream 1% Luliconazole Cream 1% Bausch Health Americas, Inc. marketed Imidazole antifungal Lanosterol 14α-demethylase (CYP51)
Ketoconazole 2% Shampoo Ketoconazole 2% Shampoo Fakultas Kedokteran Universitas Indonesia marketed Imidazole antifungal Fungal cytochrome P450 (CYP51 / lanosterol 14α-demethylase)
Topical Clotrimazole cream Topical Clotrimazole cream Hayat Abad Medical Complex, Peshawar marketed Imidazole antifungal Fungal lanosterol 14α-demethylase (CYP51)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Imidazole antifungal class)

  1. Galderma R&D · 2 drugs in this class
  2. Bayer · 2 drugs in this class
  3. AmDerma · 2 drugs in this class
  4. Jinnah Postgraduate Medical Centre · 2 drugs in this class
  5. Ache Laboratorios Farmaceuticos S.A. · 2 drugs in this class
  6. Jamaica Hospital Medical Center · 1 drug in this class
  7. Johnson & Johnson (Janssen) · 1 drug in this class
  8. Laboratoire Innotech International · 1 drug in this class
  9. PAEC General Hospital, Islamabad · 1 drug in this class
  10. Peking University Shenzhen Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Econazole Nitrate Cream 1% — Competitive Intelligence Brief. https://druglandscape.com/ci/econazole-nitrate-cream-1. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: